Concerns Raised Over Prostate Cancer Screening After Biden’s Diagnosis

Former President Joe Biden’s recent diagnosis of an aggressive form of prostate cancer has sparked discussions about screening and prevention practices.

The US Preventive Services Task Force (USPSTF) suggests that men between the ages of 55 and 69 should consult healthcare providers about the benefits and risks associated with PSA screening, making individual decisions based on those discussions. Meanwhile, it recommends that men over 70 forego such screenings altogether.

Dr. Sean Dason, a urological oncologist at Ohio State University’s Comprehensive Cancer Center, points out that although several institutions provide guidelines, the USPSTF is often seen as a primary resource. He emphasizes the importance of dialogue between healthcare providers and men in their 50s and 60s regarding screening options.

“It’s critical that they engage in conversations about prostate cancer and the role of PSA testing, including the potential benefits and drawbacks,” he explained.

Potential Risks of Screening and Treatment

There’s some debate about the necessity of screening for men under 50. Historically, the nuances of when to treat prostate cancer weren’t well understood, leading to missteps in active surveillance protocols.

Dr. Dason noted that some men may face overtreatment post-diagnosis. In certain circumstances, the cancer might not lead to serious health issues, yet treatments could cause unpleasant side effects, such as urinary problems and sexual dysfunction.

“Studies indicate that PSA screening has significantly declined among men over 40, likely due to USPSTF’s recommendations,” he mentioned.

“It’s entirely possible to receive a prostate cancer diagnosis that doesn’t actually impact your life or health,” he added. “Yet the treatment may end up being more harmful than the cancer itself.”

While there is limited evidence that screening in men over 70 prevents deaths from prostate cancer, Dr. Dason remarked that the negative effects of treatment tend to escalate with age. Still, he maintained that screening could be life-saving in some cases, making it crucial for patients to consult with their doctors.

Screening for Men Over 70

Dr. Marc Siegel, a senior medical analyst at Fox News, expressed concerns about the lack of recommended screenings for prostate cancer in men over 70. He believes this is particularly alarming given the significant number of new prostate cancer diagnoses, which exceed 300,000 annually in the US, leading to over 35,000 deaths, many preventable through earlier detection.

“I advocate for screening every man over 45, regardless of his age,” Dr. Siegel stated.

He pointed out that advancements in treatment have made various options more tolerable and effective for men of all ages.

Some critics argue that because Biden is the president, he should be under heightened scrutiny for prostate cancer screening. However, Dr. Siegel maintains that all men, starting at age 45, should be encouraged to pursue screening.

Dr. Dason echoes the sentiment that certain men over 70 could still be appropriate candidates for screening, especially if they’re in good health and have a reasonable life expectancy, as a serious prostate cancer diagnosis could greatly affect their quality of life and longevity.

Conversely, those with limited life expectancy may face more risks than benefits from such screenings, according to Dr. Dason. He concludes by urging men to consider their unique situations and consult their healthcare providers.